This person has declared the following competing interest:
Has received speaking fees and sponsorship for conference attendance (ERS 2014) from AstraZeneca; sponsorship from Olympus to attend ANZ interventional pulmonologist meeting in 2015 and 2016; honoraria from Pfizer (2014) and MSD (2016) for attending advisory board meetings.
